172 related articles for article (PubMed ID: 2169575)
41. 111In-octreotide scintigraphy in oncology.
Krenning EP; Kwekkeboom DJ; Reubi JC; Van Hagen PM; van Eijck CH; Oei HY; Lamberts SW
Metabolism; 1992 Sep; 41(9 Suppl 2):83-6. PubMed ID: 1355591
[TBL] [Abstract][Full Text] [Related]
42. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas.
Reubi JC; Horisberger U; Essed CE; Jeekel J; Klijn JG; Lamberts SW
Gastroenterology; 1988 Sep; 95(3):760-3. PubMed ID: 2899530
[TBL] [Abstract][Full Text] [Related]
43. Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: lessons from the comparison of anti-sst2A antibodies with somatostatin receptor autoradiography.
Körner M; Eltschinger V; Waser B; Schonbrunn A; Reubi JC
Am J Surg Pathol; 2005 Dec; 29(12):1642-51. PubMed ID: 16327437
[TBL] [Abstract][Full Text] [Related]
44. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors.
Reubi JC; Waser B; Sheppard M; Macaulay V
Int J Cancer; 1990 Feb; 45(2):269-74. PubMed ID: 1968052
[TBL] [Abstract][Full Text] [Related]
45. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
Reubi JC; Schaer JC; Waser B; Mengod G
Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
[TBL] [Abstract][Full Text] [Related]
46. Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from Mastomys gastric tumors.
Reubi JC; Waser B; Horisberger U; Halter F; Soroka CJ; Kumar RR; Goldenring JR; Modlin IM
Endocrinology; 1992 Jul; 131(1):166-72. PubMed ID: 1319317
[TBL] [Abstract][Full Text] [Related]
47. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.
Bakker WH; Krenning EP; Reubi JC; Breeman WA; Setyono-Han B; de Jong M; Kooij PP; Bruns C; van Hagen PM; Marbach P
Life Sci; 1991; 49(22):1593-601. PubMed ID: 1658516
[TBL] [Abstract][Full Text] [Related]
48. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
Kvols LK; Reubi JC; Horisberger U; Moertel CG; Rubin J; Charboneau JW
Yale J Biol Med; 1992; 65(5):505-18; discussion 531-6. PubMed ID: 1364090
[TBL] [Abstract][Full Text] [Related]
49. The role of somatostatin and dopamine D2 receptors in endocrine tumors.
Gatto F; Hofland LJ
Endocr Relat Cancer; 2011 Dec; 18(6):R233-51. PubMed ID: 22135243
[TBL] [Abstract][Full Text] [Related]
50. Somatostatin-receptor scintigraphy in primary breast cancer.
van Eijck CH; Krenning EP; Bootsma A; Oei HY; van Pel R; Lindemans J; Jeekel J; Reubi JC; Lamberts SW
Lancet; 1994 Mar; 343(8898):640-3. PubMed ID: 7906813
[TBL] [Abstract][Full Text] [Related]
51. Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs.
Matrone C; Pivonello R; Colao A; Cappabianca P; Cavallo LM; Del Basso De Caro ML; Taylor JE; Culler MD; Lombardi G; Di Renzo GF; Annunziato L
Neuroendocrinology; 2004 Mar; 79(3):142-8. PubMed ID: 15103227
[TBL] [Abstract][Full Text] [Related]
52. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
Metabolism; 1990 Sep; 39(9 Suppl 2):152-5. PubMed ID: 2169572
[TBL] [Abstract][Full Text] [Related]
53. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status.
Reubi JC; Landolt AM
J Clin Endocrinol Metab; 1989 Apr; 68(4):844-50. PubMed ID: 2537844
[TBL] [Abstract][Full Text] [Related]
54. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
Reubi JC; Chayvialle JA; Franc B; Cohen R; Calmettes C; Modigliani E
Lab Invest; 1991 Apr; 64(4):567-73. PubMed ID: 1673164
[TBL] [Abstract][Full Text] [Related]
55. Somatostatin, cortistatin and their receptors in tumours.
Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
[TBL] [Abstract][Full Text] [Related]
56. Somatostatin receptor imaging and therapy of pancreatic endocrine tumors.
van Eijck CH; de Jong M; Breeman WA; Slooter GD; Marquet RL; Krenning EP
Ann Oncol; 1999; 10 Suppl 4():177-81. PubMed ID: 10436816
[TBL] [Abstract][Full Text] [Related]
57. Characterization of covalently cross-linked somatostatin receptors in hamster beta cell insulinoma.
Cotroneo P; Marie JC; Rosselin G
Eur J Biochem; 1988 May; 174(1):219-24. PubMed ID: 2897292
[TBL] [Abstract][Full Text] [Related]
58. Lack of evidence for autocrine feedback regulation by somatostatin in somatostatin receptor-containing meningiomas.
Reubi JC; Mengod G; Palacios JM; Horisberger U; Hackeng WH; Lamberts SW
Cell Growth Differ; 1990 Jun; 1(6):299-303. PubMed ID: 1980601
[TBL] [Abstract][Full Text] [Related]
59. Perspectives of new potential therapeutic applications of somatostatin analogs.
Pawlikowski M; Melen-Mucha G
Neuro Endocrinol Lett; 2003; 24(1-2):21-7. PubMed ID: 12743527
[TBL] [Abstract][Full Text] [Related]
60. Somatostatin receptors in the thymus.
Ferone D; van Hagen PM; Colao A; Annunziato L; Lamberts SW; Hofland LJ
Ann Med; 1999 Oct; 31 Suppl 2():28-33. PubMed ID: 10574152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
